sub-Tenon steroid Introduction (What it is)
A sub-Tenon steroid is a corticosteroid medication placed into the sub-Tenon space around the eye.
It is used to reduce inflammation in and around the eye when drops alone may not be enough.
It is most commonly used in ophthalmology clinics for inflammatory eye disease and swelling at the back of the eye.
It is not the same as an “in-the-eye” (intravitreal) injection, although both may be used for similar conditions.
Why sub-Tenon steroid used (Purpose / benefits)
The main purpose of a sub-Tenon steroid is to deliver anti-inflammatory medication close to ocular tissues while limiting how much medication needs to circulate through the whole body.
Corticosteroids (often simply called “steroids”) reduce inflammation by calming immune activity. In eye care, inflammation can cause symptoms (pain, redness, light sensitivity), blur vision, and contribute to tissue swelling—especially in conditions that affect the retina or macula (the central vision area).
A sub-Tenon steroid is often considered when:
- Inflammation is moderate to significant and needs stronger treatment than topical drops alone.
- The target problem involves deeper tissues (for example, posterior segment inflammation or macular edema) where eye drops may have limited penetration.
- A clinician wants a longer-acting “depot” effect (a medication reservoir) that can work over time without frequent dosing.
Potential benefits in general terms include:
- Local delivery near the eye tissues involved in inflammation.
- Reduced treatment burden compared with frequent drop schedules (varies by clinician and case).
- A way to treat or support treatment of inflammatory causes of vision change, such as swelling in the macula.
Indications (When ophthalmologists or optometrists use it)
Common clinical situations where a sub-Tenon steroid may be used include:
- Non-infectious uveitis (inflammation inside the eye), especially when posterior involvement is present
- Cystoid macular edema (CME) related to inflammation or after certain eye surgeries (varies by clinician and case)
- Inflammation associated with retinal conditions where local steroid therapy is appropriate (varies by diagnosis)
- Post-operative ocular inflammation when additional local steroid effect is desired (varies by surgeon and procedure)
- Some cases of scleritis or episcleritis as part of a broader plan (case-dependent)
- Adjunct therapy when systemic medications are used but additional local control is needed (varies by clinician and case)
Contraindications / when it’s NOT ideal
A sub-Tenon steroid is not suitable for every patient or condition. Situations where it may be avoided or approached cautiously include:
- Suspected or confirmed ocular infection (for example, herpetic eye disease, fungal infection, bacterial infection), because steroids can worsen infections
- Uncontrolled glaucoma or a history of significant steroid-induced intraocular pressure (IOP) rise (“steroid responder”)
- Known allergy or hypersensitivity to the steroid preparation or its preservatives (varies by formulation)
- Significant thinning of the sclera (the white wall of the eye) or other structural concerns that may increase procedural risk (case-dependent)
- Situations where the diagnosis is uncertain and infection has not been adequately ruled out
- When a shorter-acting, more adjustable therapy is preferred (for example, drops that can be tapered quickly)
- When an alternative delivery route is more appropriate for the location/severity of disease (varies by clinician and case)
“Not ideal” does not always mean “never used.” In real practice, suitability depends on diagnosis, anatomy, previous response to steroids, and clinician judgment.
How it works (Mechanism / physiology)
Mechanism of action (what the steroid does)
Corticosteroids reduce inflammation through multiple pathways, including:
- Decreasing inflammatory signaling molecules (cytokines and other mediators)
- Reducing leakage from inflamed blood vessels, which can lessen tissue swelling
- Stabilizing cellular and vascular membranes involved in inflammatory responses
In eye disease, these effects can translate into reduced inflammatory cell activity and decreased fluid accumulation—important in conditions that cause retinal or macular swelling.
Where it works (key anatomy)
“Sub-Tenon” refers to a potential space beneath Tenon’s capsule, a thin connective tissue layer that envelops much of the eyeball. This space lies outside the sclera but still around the globe.
Because the medication is placed around the eye rather than on the surface, it can diffuse toward deeper tissues compared with a surface drop. It is still considered an extraocular (outside the eyeball) delivery method.
Onset, duration, and reversibility
- Onset: The anti-inflammatory effect may begin within days, but timing varies by medication choice, dose, and the condition being treated.
- Duration: Many commonly used preparations act as a local depot and may last weeks to months, but this varies by clinician and case.
- Reversibility: Unlike a drop that can be stopped immediately, a depot steroid cannot be “removed” once placed. Clinicians instead manage side effects (such as IOP rise) with monitoring and additional treatment if needed.
sub-Tenon steroid Procedure overview (How it’s applied)
A sub-Tenon steroid is administered as a periocular injection performed in a clinic or procedure room setting. Specific techniques vary, but the general workflow is often similar.
1) Evaluation / exam
Clinicians typically:
- Confirm the working diagnosis (for example, inflammatory macular edema vs. infection)
- Review eye pressure history, glaucoma risk, and prior steroid responses
- Check baseline vision, intraocular pressure, and ocular findings
- Consider imaging such as OCT (optical coherence tomography) when macular swelling is part of the problem (varies by clinician and case)
2) Preparation
Common preparation steps may include:
- Explaining the rationale, expected benefits, and potential risks in general terms
- Reviewing medication allergies and relevant medical history
- Using topical anesthetic to reduce discomfort
- Cleaning the eye area with an antiseptic to reduce infection risk
3) Intervention (delivery of the medication)
In general terms, the clinician:
- Accesses the sub-Tenon space (often using a specialized blunt cannula in many techniques)
- Delivers the corticosteroid into the targeted periocular location (often posterior sub-Tenon for posterior segment conditions)
- Uses technique choices that aim to minimize trauma to surrounding tissues (technique varies)
This is a clinical procedure, and the exact approach (instrument choice, location, patient positioning) varies by training and case.
4) Immediate checks
Right after the injection, the care team may:
- Check vision briefly and look for surface irritation or bleeding
- Assess for significant pain or other unexpected symptoms
- Measure IOP in some settings when clinically indicated (varies by clinician and case)
5) Follow-up
Follow-up commonly focuses on:
- Symptom and vision changes
- Improvement on exam and/or imaging (such as OCT when relevant)
- Monitoring for steroid-related side effects—especially elevated IOP and cataract progression over time
Types / variations
Sub-Tenon steroid therapy can vary by medication, technique, and clinical goal.
By medication (examples)
Commonly used corticosteroids in periocular injections may include:
- Triamcinolone acetonide (often used as a longer-acting depot formulation)
- Dexamethasone (formulations and duration vary)
- Methylprednisolone (used in some contexts)
The exact preparation, concentration, and additives can vary by material and manufacturer, and clinicians choose based on availability, diagnosis, and treatment goals.
By injection location
- Posterior sub-Tenon: Medication is delivered toward the back of the eye, commonly selected when the retina/macula is involved.
- Anterior sub-Tenon: More forward placement may be considered for certain anterior segment inflammatory needs (case-dependent).
By treatment strategy
- Single treatment vs. repeat injections: Some conditions require repeat therapy if inflammation recurs, while others may respond to one treatment (varies by clinician and case).
- Standalone vs. combination therapy: A sub-Tenon steroid may be used along with drops, oral medications, or other immunomodulatory therapies depending on the underlying condition.
Pros and cons
Pros:
- Delivers anti-inflammatory medication close to ocular tissues without systemic dosing in many cases
- Can provide longer-lasting effect than drops alone (varies by medication and case)
- Useful when adherence to frequent eye drops is difficult (varies by clinician and case)
- May help control inflammation affecting deeper eye structures where drops may be less effective
- Often performed in an outpatient setting
- Can be integrated into broader treatment plans for inflammatory eye disease
Cons:
- Steroid side effects can still occur, including elevated intraocular pressure and cataract progression (risk varies)
- Not immediately reversible once a depot medication is placed
- Procedure-related risks exist, such as bruising, swelling, bleeding on the eye surface, or discomfort
- Rare but serious complications are possible (for example, significant injury to ocular tissues or infection), with risk depending on anatomy and technique
- May not be appropriate if infection is suspected, because steroids can worsen infectious disease
- Effect may be incomplete, temporary, or require additional treatments (varies by clinician and case)
Aftercare & longevity
After a sub-Tenon steroid, “aftercare” usually means monitoring rather than intensive at-home treatment. The experience and recovery vary: some people notice mild soreness, redness, or eyelid heaviness for a short period, while others have minimal symptoms.
What can affect outcomes
Several factors influence how long the effect lasts and how well inflammation improves:
- Underlying diagnosis and severity: Chronic inflammatory diseases may relapse and need ongoing management.
- Location of inflammation: Conditions centered in the posterior segment may respond differently than primarily anterior inflammation.
- Individual steroid response: Some people have a stronger IOP rise or a more robust clinical response than others.
- Coexisting eye disease: Glaucoma risk, existing cataract, or retinal disease can affect monitoring priorities and overall visual outcome.
- Medication choice and depot behavior: Duration and tissue penetration vary by medication and formulation.
Monitoring over time
Clinicians commonly monitor:
- Intraocular pressure (IOP): Steroid-related IOP elevation can appear after treatment and may require management.
- Lens clarity: Steroids can contribute to cataract progression over time, especially with repeated exposure.
- Inflammation control: Exams and, when appropriate, retinal imaging help determine whether swelling/inflammation is improving.
Longevity is not the same for everyone; it varies by clinician and case, and by the inflammatory condition being treated.
Alternatives / comparisons
The “best” option depends on the diagnosis, how severe the inflammation is, whether infection is a concern, and the patient’s risk factors (especially glaucoma).
Compared with topical steroid eye drops
- Drops are non-invasive and can be started or stopped quickly, which is useful when frequent dose adjustments are needed.
- Sub-Tenon steroid can provide stronger or longer local effect in some posterior conditions, but it is procedural and not instantly reversible.
Compared with oral (systemic) steroids
- Systemic steroids treat inflammation throughout the body and may be used when eye disease is part of a systemic inflammatory condition. They carry broader systemic risks and require medical supervision.
- Sub-Tenon steroid focuses therapy near the eye and may reduce the need for systemic exposure in some cases (varies by clinician and case), but it does not address non-ocular inflammation.
Compared with intravitreal steroid therapy
- Intravitreal steroids deliver medication directly inside the eye and can be effective for retinal/macular inflammation and edema, but they are intraocular procedures with their own risk profile.
- Sub-Tenon steroid is extraocular and may be chosen when clinicians want periocular delivery rather than an intraocular injection, depending on the condition and risk considerations.
Compared with non-steroidal options
- NSAID eye drops may help in certain inflammatory or post-surgical swelling scenarios but are generally not as potent as corticosteroids for many uveitic conditions (choice varies by clinician and case).
- Immunomodulatory therapy (IMT)/biologics may be considered for chronic, recurrent, or systemic inflammatory disease, often coordinated with specialists. These are typically longer-term strategies rather than rapid, local anti-inflammatory measures.
Compared with observation/monitoring
- Observation may be reasonable when inflammation is mild, stable, or improving, and when the risk of steroid side effects outweighs likely benefit.
- Sub-Tenon steroid is usually considered when active inflammation threatens vision, causes significant symptoms, or has not responded sufficiently to less invasive treatment (varies by clinician and case).
sub-Tenon steroid Common questions (FAQ)
Q: Is a sub-Tenon steroid the same as an injection “into the eye”?
No. A sub-Tenon steroid is placed around the eye in the sub-Tenon space, which is outside the eyeball. An intravitreal injection places medication inside the eye and is a different route with different considerations.
Q: Does the injection hurt?
Discomfort varies from person to person. Clinicians typically use numbing drops and other comfort measures, so many patients report pressure or mild soreness rather than sharp pain, but experiences differ.
Q: How long does a sub-Tenon steroid last?
Duration depends on the medication used, the amount delivered, and how the individual’s inflammation behaves. In many cases the effect is longer than standard eye drops, but the exact timeframe varies by clinician and case.
Q: What conditions does it treat most often?
It is commonly used for non-infectious inflammatory eye disease, including some types of uveitis and inflammatory macular edema. Whether it is appropriate depends on confirming the diagnosis and ruling out infection when relevant.
Q: What are the main risks people should know about?
Key risks include increased intraocular pressure (which matters for glaucoma risk), cataract progression over time, and procedure-related irritation or bleeding on the surface of the eye. Rare but serious complications can occur, and risk varies by anatomy and technique.
Q: Will I need follow-up visits after a sub-Tenon steroid?
Follow-up is commonly used to confirm that inflammation is improving and to monitor for steroid-related side effects, especially eye pressure changes. The schedule and testing vary by clinician and case.
Q: Can I drive afterward or go back to screens/work?
Plans vary by clinic and by how the eye feels after the procedure. Temporary blur, watering, or irritation can occur, so clinicians often individualize guidance based on comfort, vision, and whether the eye was patched or dilated (varies by clinician and case).
Q: How much does a sub-Tenon steroid cost?
Cost varies widely by region, facility, insurance coverage, and the specific medication used. Clinic billing may include both the medication and the procedure, and out-of-pocket amounts vary.
Q: If it works once, can it be repeated?
Sometimes it can be repeated, particularly for recurrent inflammatory disease or macular edema, but repeat exposure may increase the chance of side effects like elevated IOP or cataract progression. The decision is individualized and depends on response and risk factors.
Q: How is it different from steroid eye drops after surgery?
Drops treat inflammation mainly at the ocular surface and anterior segment and can be adjusted day to day. A sub-Tenon steroid is a localized depot approach that may be considered when deeper inflammation or stronger/longer effect is needed, depending on the surgical context and the clinician’s assessment.